Data from Codiak’s exoSTING™ Preclinical Development Program for the Treatment of Solid Tumors Published in the Nature Research Publication, Communications Biology

Ads

You May Also Like

ABLYNX ANNOUNCES WARRANT EXERCISE

REGULATED INFORMATION GHENT, Belgium, 11 August 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] ...

Eurobio Scientific reaches the €50M sales mark in 2018

EUROBIO SCIENTIFIC REACHES THE €50M SALES MARK IN 2018 Eurobio Scientific consolidated sales reached ...